Molecular identification of Ganoderma lucidum from Iran

Authors

  • Ashrafalsadat Hatamian-Zarmi Assistant Prof., Department of Life Science Engineering, Faculty of New Sciences and Technologies, University of Tehran, 14395-1561, Tehran, Iran ([email protected])
  • Motaharehsadat Heydarian MSc Graduate, Microbial Biotechnology, Department of Life Science Engineering, Faculty of New Sciences and Technologies, University of Tehran, 14395-1561, Tehran, Iran
Abstract:

Medicinal mushroom Ganoderma lucidum has been used in East Asia for centuries in order to prevent and treat a variety of diseases such as hepatitis, immunological disorders and cancers. In fact, this fungus contains a vast source of polysaccharides, proteins and secondary metabolites with anti-tumor and immuno-modulatory properties. Up to now, a variety of drug metabolites extracted from G. lucidum have reached the stage of commercial production. Recently, in addition to China, Korea and Japan, this valuable fungus has been identified in different parts of the world such as Pakistan, Malaysia and Turkey. In 2007, G. lucidum has been identified in northern forests of Iran; however, molecular identification of this fungus has not been reported yet. The aim of this study was, therefore, to identify this fungus collected from northern Iran by analyzing ITS-5.8S rDNA sequence. The result of this experiment confirmed that the collected specimen were G. lucidum.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Comparison between antioxidant activity and bioactive compounds of Ganoderma applanatum (Pers.) Pat. and Ganoderma lucidum (Curt.) P. Karst from Iran

Members of Ganoderma genus, belong to Basidiomycota, such as Ganoderma applanatum and Ganoderma lucidum have been noticed in traditional and modern medicine and pharmacology for their medicinal properties and bioactive compounds. The present study is undertaken to determine whether there is difference between chemical properties of G. applanatum and G. lucidum. The fresh mature fruiting bodies ...

full text

From 2000years of Ganoderma lucidum to recent developments in nutraceuticals.

Medicinal mushrooms have been used for centuries as nutraceuticals to improve health and to treat numerous chronic and infectious diseases. One such mushroom is Ganoderma lucidum, commonly known as Lingzhi, a species revered as a medicinal mushroom for treating assorted diseases and prolonging life. The fungus is found in diverse locations, and this may have contributed to confusion regarding t...

full text

Identification of a laccase Glac15 from Ganoderma lucidum 77002 and its application in bioethanol production

BACKGROUND Laccases have potential applications in detoxification of lignocellulosic biomass after thermochemical pretreatment and production of value-added products or biofuels from renewable biomass. However, their application in large-scale industrial and environmental processes has been severely thwarted by the high cost of commercial laccases. Therefore, it is necessary to identify new lac...

full text

Structure Identification and Anti-Cancer Pharmacological Prediction of Triterpenes from Ganoderma lucidum.

Ganoderma triterpenes (GTs) are the major secondary metabolites of Ganoderma lucidum, which is a popularly used traditional Chinese medicine for complementary cancer therapy. In the present study, systematic isolation, and in silico pharmacological prediction are implemented to discover potential anti-cancer active GTs from G. lucidum. Nineteen GTs, three steroids, one cerebroside, and one thym...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 17  issue 2

pages  188- 192

publication date 2017-02-19

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023